Advancing effective prevention, care, support, and health equity in HIV, HCV, STIs, LGBTQ health and harm reduction
 
HealthHIV Logo Putting Health First

Optimizing PrEP Access through Advocacy


This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an educational grant from Gilead Sciences, Inc.

Gilead

This activity will focus on medication therapy management protocols and their impact on prescription drug coverage policies. It also will look at PrEP access through a health equity lens and will include a review of the drug utilization review process, insurance models, and health impact analysis—considering the impact of each on patients and care.

Target Audience

The educational design of this activity addresses the needs of clinical and community pharmacists involved in the treatment of patients at risk for HIV infection as well as managed care pharmacists, pharmacy benefit managers, and specialty pharmacists.

Educational Objectives 

After completing this activity, the participant should be better able to:

  • Describe how Medication Therapy Management (MTM) protocols impact prescription drug coverage policies, PrEP access, and health equity
  • Review the basics of the Drug Utilization Review (DUR) process and its relationship to and impact on public and private insurance models
  • Discuss how PrEP providers, practitioners, and advocates can participate in effective MTM protocols.

Faculty
  • Melissa Badowski, PharmD, MPH
    Clinical Associate Professor, University of Illinois at Chicago, College of Pharmacy
  • Scott Bertani, MA
    Director of Advocacy, HealthHIV

HealthHIV

1630 Connecticut Ave. NW
Suite 500
Washington, DC 20009

202-232-6749
[email protected]

Connect

Get the latest training opportunities, news, and more delivered directly to your inbox.

Get Updates

© Copyright 2025 HealthHIV. All rights reserved. | Privacy Policy | Site Map | About